|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-2-23
|
|
pubmed:abstractText |
Iron is used as an adjunct therapy to treat anaemia in dialysis patients. However, iron may harbour detrimental effects in being a nutrient for invading pathogens or by modulating immune pathways. Thus, we prospectively studied the effects of iron treatment towards monocyte immune function.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antimicrobial Cationic Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/CD71 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Cation Transport Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ferritins,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Iron, Dietary,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Transferrin,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/hepcidin,
http://linkedlifedata.com/resource/pubmed/chemical/metal transporting protein 1
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1460-2385
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
977-87
|
|
pubmed:dateRevised |
2011-10-27
|
|
pubmed:meshHeading |
pubmed-meshheading:20826742-Aged,
pubmed-meshheading:20826742-Antigens, CD,
pubmed-meshheading:20826742-Antimicrobial Cationic Peptides,
pubmed-meshheading:20826742-Blotting, Western,
pubmed-meshheading:20826742-Cation Transport Proteins,
pubmed-meshheading:20826742-Cells, Cultured,
pubmed-meshheading:20826742-Female,
pubmed-meshheading:20826742-Ferritins,
pubmed-meshheading:20826742-Humans,
pubmed-meshheading:20826742-Interleukin-6,
pubmed-meshheading:20826742-Iron, Dietary,
pubmed-meshheading:20826742-Kidney Failure, Chronic,
pubmed-meshheading:20826742-Male,
pubmed-meshheading:20826742-Middle Aged,
pubmed-meshheading:20826742-Monocytes,
pubmed-meshheading:20826742-Prognosis,
pubmed-meshheading:20826742-RNA, Messenger,
pubmed-meshheading:20826742-Receptors, Transferrin,
pubmed-meshheading:20826742-Renal Dialysis,
pubmed-meshheading:20826742-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:20826742-Risk Factors,
pubmed-meshheading:20826742-Survival Rate,
pubmed-meshheading:20826742-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Impact of iron treatment on immune effector function and cellular iron status of circulating monocytes in dialysis patients.
|
|
pubmed:affiliation |
Department of Internal Medicine I, Clinical Immunology and Infectious Diseases, Medical University of Innsbruck, Innsbruck, Austria.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
